$PRTK Paratek Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Paratek Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Paratek Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Paratek Pharmaceuticals, Inc. for free.

CIK Number: 0001178711
IRS Number: 330960223
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PRTK
Company Address: 75 PARK PLAZA 4TH FLOOR BOSTON 02116
Former name: NOVACEA INC, date of change: 2002-07-24
Former name: Transcept Pharmaceuticals Inc, date of change: 2009-01-30

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.

Market Capitalization: $346.19M
Prev close: $15.25
Average Daily Volume: 160,755
Days Low: $15.05
Year Low: $9.80
Year High: $18.92

Paratek Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BIGHAM MICHAELExec. Chairman of the Board542,1678,268,047shares bought: 612,755 / shares sold: -136,188 STRONG BUYMay 14 20203 months ago
Brenner Randall B.Chief Development & Regulatory130,8131,994,898shares bought: 57,000 / shares sold: -25,199 STRONG BUYMay 14 20203 months ago
Haskel William M.Sr. VP, Sec. & General Counsel198,6903,030,023shares bought: 220,000 / shares sold: -45,364 STRONG BUYMay 14 20203 months ago
Loh EvanCEO552,0088,418,122shares bought: 592,478 / shares sold: -128,043 STRONG BUYMay 14 20203 months ago
Woodrow AdamPresident & Chief Commercial270,6734,127,763shares bought: 287,000 / shares sold: -70,504 STRONG BUYMay 14 20203 months ago

View all Paratek Pharmaceuticals, Inc. insiders.

Paratek Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 14 2020PRTKParatek Pharmaceut ...Haskel William M.Sr. VP, Sec. & Gene ...SellS4.754,66622,164198,690203.4 K to 198.7 K (-2.29 %)
May 14 2020PRTKParatek Pharmaceut ...Brenner Randall B.Chief Development & ...SellS4.756,19829,441130,813137 K to 130.8 K (-4.52 %)
May 14 2020PRTKParatek Pharmaceut ...Woodrow AdamPresident & Chief C ...SellS4.754,79822,791270,673275.5 K to 270.7 K (-1.74 %)
May 14 2020PRTKParatek Pharmaceut ...Loh EvanCEOSellS4.759,59545,576552,008561.6 K to 552 K (-1.71 %)
May 14 2020PRTKParatek Pharmaceut ...BIGHAM MICHAELExec. Chairman of t ...SellS4.6812,25057,330542,167554.4 K to 542.2 K (-2.21 %)
Feb 21 2020PRTKParatek Pharmaceut ...Franson Timothy RDirectorOption ExerciseA3.517,00024,5707,000
Feb 21 2020PRTKParatek Pharmaceut ...Franson Timothy RDirectorGrantA0.009,000030,00021 K to 30 K (+42.86 %)
Feb 21 2020PRTKParatek Pharmaceut ...Radie Robert SDirectorOption ExerciseA3.517,00024,5707,000
Feb 21 2020PRTKParatek Pharmaceut ...Radie Robert SDirectorGrantA0.009,000023,25014.3 K to 23.3 K (+63.16 %)
Feb 21 2020PRTKParatek Pharmaceut ...Stein JeffreyDirectorOption ExerciseA3.517,00024,5707,000
Feb 21 2020PRTKParatek Pharmaceut ...Stein JeffreyDirectorGrantA0.009,000026,62517.6 K to 26.6 K (+51.06 %)
Feb 21 2020PRTKParatek Pharmaceut ...Dietz Thomas JohnDirectorOption ExerciseA3.517,00024,5707,000
Feb 21 2020PRTKParatek Pharmaceut ...Dietz Thomas JohnDirectorGrantA0.009,000021,00012 K to 21 K (+75.00 %)
Feb 21 2020PRTKParatek Pharmaceut ...Peterson KristineDirectorOption ExerciseA3.517,00024,5707,000
Feb 21 2020PRTKParatek Pharmaceut ...Peterson KristineDirectorGrantA0.009,000030,00021 K to 30 K (+42.86 %)

View all Paratek Pharmaceuticals, Inc. insider transactions.